150 related articles for article (PubMed ID: 11994561)
1. Advanced prostate cancer activates coagulation: a controlled study of activation markers of coagulation in ambulatory patients with localized and advanced prostate cancer.
Kohli M; Fink LM; Spencer HJ; Zent CS
Blood Coagul Fibrinolysis; 2002 Jan; 13(1):1-5. PubMed ID: 11994561
[TBL] [Abstract][Full Text] [Related]
2. The use of coagulation activation markers (soluble fibrin polymer, TpP, prothrombin fragment 1.2, thrombin-antithrombin, and D-dimer) in the assessment of hypercoagulability in patients with inherited and acquired prothrombotic disorders.
Arkel YS; Paidas MJ; Ku DH
Blood Coagul Fibrinolysis; 2002 Apr; 13(3):199-205. PubMed ID: 11943933
[TBL] [Abstract][Full Text] [Related]
3. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
[TBL] [Abstract][Full Text] [Related]
4. [Activation of hemostasis in patients with chronic cholecystitis].
Kłoczko J; Lewandowski JJ; Galar M; Mazgajska-Barczyk K; Panek M
Pol Merkur Lekarski; 2001 Jan; 10(55):19-20. PubMed ID: 11320544
[TBL] [Abstract][Full Text] [Related]
5. Plasma thrombin-antithrombin complex, prothrombin fragments 1 and 2, and D-dimer levels are elevated after endovascular but not open repair of infrarenal abdominal aortic aneurysm.
Bailey MA; Griffin KJ; Sohrabi S; Whalley DJ; Johnson AB; Baxter PD; Ariëns RA; Scott DJ
J Vasc Surg; 2013 Jun; 57(6):1512-8. PubMed ID: 23490299
[TBL] [Abstract][Full Text] [Related]
6. Plasma markers of hypercoagulability in patients with serious infections and risk of septic shock.
Psuja P; Zozulińska M; Turowiecka Z; Cieślikowski W; Vinazzer H; Zawilska K
Clin Appl Thromb Hemost; 2002 Jul; 8(3):225-30. PubMed ID: 12361199
[TBL] [Abstract][Full Text] [Related]
7. Markers of activated coagulation in patients with factor V Leiden and/or G20210A prothrombin gene mutation.
Gouin-Thibault I; Arkam R; Nassiri S; de la Tourette A; Conard J; Horellou MH; Elalamy I; Samama MM
Thromb Res; 2002 Jul; 107(1-2):7-11. PubMed ID: 12413582
[TBL] [Abstract][Full Text] [Related]
8. Transdermal estradiol therapy for prostate cancer reduces thrombophilic activation and protects against thromboembolism.
Ockrim JL; Lalani el-N; Kakkar AK; Abel PD
J Urol; 2005 Aug; 174(2):527-33; discussion 532-3. PubMed ID: 16006886
[TBL] [Abstract][Full Text] [Related]
9. Prothrombin fragment 1.2 and modified antithrombin as predictors of disseminated intravascular coagulation and thrombotic risk in thermal injury.
Kowal-Vern A; Walenga JM; Hoppensteadt D; Gamelli RL
J Burn Care Res; 2013; 34(4):459-64. PubMed ID: 23202877
[TBL] [Abstract][Full Text] [Related]
10. Comparison of prothrombin fragment 1 + 2 with thrombin-antithrombin III complex in plasma of patients with disseminated intravascular coagulation.
Takahashi H; Wada K; Niwano H; Shibata A
Blood Coagul Fibrinolysis; 1992 Dec; 3(6):813-8. PubMed ID: 1336986
[TBL] [Abstract][Full Text] [Related]
11. Markers of platelet, endothelial cell and blood coagulation activation in leprosy patients with antiphospholipid antibodies.
Martinuzzo ME; de Larrañaga GF; Forastiero RR; Pelegri Y; Fariña MH; Alonso BS; Kordich LC; Carreras LO
Clin Exp Rheumatol; 2002; 20(4):477-83. PubMed ID: 12175102
[TBL] [Abstract][Full Text] [Related]
12. Changes in molecular markers of hemostatic and fibrinolytic activation under various sampling conditions using vacuum tube samples from healthy volunteers.
Omote M; Asakura H; Takamichi S; Shibayama M; Yoshida T; Kadohira Y; Maekawa M; Yamazaki M; Morishita E; Nakao S; Wada T
Thromb Res; 2008; 123(2):390-5. PubMed ID: 18579183
[TBL] [Abstract][Full Text] [Related]
13. Prothrombin fragments F1+2, thrombin-antithrombin III complexes, fibrin monomers and fibrinogen in patients with coronary atherosclerosis.
Giannitsis E; Siemens HJ; Mitusch R; Tettenborn I; Wiegand U; Schmücker G; Sheikhzadeh A; Stierle U
Int J Cardiol; 1999 Mar; 68(3):269-74. PubMed ID: 10213277
[TBL] [Abstract][Full Text] [Related]
14. High F1.2 fragment of prothrombin, thrombin-antithrombin III complex (TAT) and soluble fibrin plasma levels demonstrate hypercoagulability induced during loco-regional thrombolytic therapy with rt-PA.
Garcia-Avello A; Garcia-Frade LJ; Gandarias C; Ocaña J; Cancelas JA; Lasso M
Thromb Res; 1994 Jan; 73(2):109-15. PubMed ID: 8171409
[TBL] [Abstract][Full Text] [Related]
15. Coagulopathy in disseminated intravascular coagulation due to abdominal sepsis: determination of prothrombin fragment 1 + 2 and other markers.
Okamoto K; Takaki A; Takeda S; Katoh H; Ohsato K
Haemostasis; 1992; 22(1):17-24. PubMed ID: 1387863
[TBL] [Abstract][Full Text] [Related]
16. Plasma tissue factor antigen in localized prostate cancer: distribution, clinical significance and correlation with haemostatic activation markers.
Langer F; Chun FK; Amirkhosravi A; Friedrich M; Leuenroth S; Eifrig B; Bokemeyer C; Francis JL
Thromb Haemost; 2007 Mar; 97(3):464-70. PubMed ID: 17334515
[TBL] [Abstract][Full Text] [Related]
17. Abnormally short activated partial thromboplastin times are related to elevated plasma levels of TAT, F1+2, D-dimer and FVIII:C.
Ten Boekel E; Bartels P
Pathophysiol Haemost Thromb; 2002; 32(3):137-42. PubMed ID: 12372929
[TBL] [Abstract][Full Text] [Related]
18. Increased lipid peroxidation correlates with platelet activation but not with markers of endothelial cell and blood coagulation activation in patients with antiphospholipid antibodies.
Martinuzzo ME; Forastiero RR; Kordich L; Carreras LO
Br J Haematol; 2001 Sep; 114(4):845-51. PubMed ID: 11564073
[TBL] [Abstract][Full Text] [Related]
19. Correlation between increased granulocyte elastase release and activation of blood coagulation in patients with lung cancer.
Gabazza E; Taguchi O; Yamakami T; Machishi M; Ibata H; Suzuki S
Cancer; 1993 Oct; 72(7):2134-40. PubMed ID: 7690680
[TBL] [Abstract][Full Text] [Related]
20. Activation of the coagulation cascade in patients with leptospirosis.
Chierakul W; Tientadakul P; Suputtamongkol Y; Wuthiekanun V; Phimda K; Limpaiboon R; Opartkiattikul N; White NJ; Peacock SJ; Day NP
Clin Infect Dis; 2008 Jan; 46(2):254-60. PubMed ID: 18171258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
